These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 23977186)
41. Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice. Tada R; Suzuki H; Takahashi S; Negishi Y; Kiyono H; Kunisawa J; Aramaki Y Int Immunopharmacol; 2018 Aug; 61():385-393. PubMed ID: 29945026 [TBL] [Abstract][Full Text] [Related]
42. [Enhancement of immune responses in rabbits with a targeted anti-caries DNA vaccine pGJA-P]. Jia R; Fan MW; Guo JH; Bian Z; Chen Z; Yu F Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 May; 39(3):248-51. PubMed ID: 15196400 [TBL] [Abstract][Full Text] [Related]
43. Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier. Gao X; Liu N; Wang Z; Gao J; Zhang H; Li M; Du Y; Gao X; Zheng A Molecules; 2021 Dec; 27(1):. PubMed ID: 35011436 [TBL] [Abstract][Full Text] [Related]
44. Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response. Pawar D; Jaganathan KS Drug Deliv; 2016; 23(1):185-94. PubMed ID: 24825494 [TBL] [Abstract][Full Text] [Related]
45. Remote glucosyltransferase-microparticle vaccine delivery induces protective immunity in the oral cavity. Smith DJ; Lam A; Barnes LA; King WF; Peacock Z; Wise DL; Trantolo DJ; Taubman MA Oral Microbiol Immunol; 2003 Aug; 18(4):240-8. PubMed ID: 12823800 [TBL] [Abstract][Full Text] [Related]
46. Enhanced immunogenicity of a genetic chimeric protein consisting of two virulence antigens of Streptococcus mutans and protection against infection. Zhang P; Jespersgaard C; Lamberty-Mallory L; Katz J; Huang Y; Hajishengallis G; Michalek SM Infect Immun; 2002 Dec; 70(12):6779-87. PubMed ID: 12438353 [TBL] [Abstract][Full Text] [Related]
48. A strong adjuvant based on glycol-chitosan-coated lipid-polymer hybrid nanoparticles potentiates mucosal immune responses against the recombinant Chlamydia trachomatis fusion antigen CTH522. Rose F; Wern JE; Gavins F; Andersen P; Follmann F; Foged C J Control Release; 2018 Feb; 271():88-97. PubMed ID: 29217176 [TBL] [Abstract][Full Text] [Related]
49. [Construction of recombinant house dust mite group 1 allergen vaccine and study on immune response induced by nasal immunization]. Shi WD; Cao W; Liu Y; Xu Y; Tao ZZ; Dai Q Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Jan; 48(1):26-31. PubMed ID: 23656812 [TBL] [Abstract][Full Text] [Related]
50. Liposomes containing anti-idiotypic antibodies: an oral vaccine to induce protective secretory immune responses specific for pathogens of mucosal surfaces. Jackson S; Mestecky J; Childers NK; Michalek SM Infect Immun; 1990 Jun; 58(6):1932-6. PubMed ID: 2341186 [TBL] [Abstract][Full Text] [Related]
51. [Immunization with targeted fusion anticaries DNA vaccine via intramuscular route:experiment with murine]. Yu F; Fan MW; Xu QA; Jia R; Guo JH; Bian Z; Chen Z; Peng B; Fan B Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):754-9. PubMed ID: 15200917 [TBL] [Abstract][Full Text] [Related]
52. Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles. Pan L; Zhang Z; Lv J; Zhou P; Hu W; Fang Y; Chen H; Liu X; Shao J; Zhao F; Ding Y; Lin T; Chang H; Zhang J; Zhang Y; Wang Y Int J Nanomedicine; 2014; 9():5603-18. PubMed ID: 25506214 [TBL] [Abstract][Full Text] [Related]
53. Protective efficacy of two new anti-caries DNA vaccines. Sun J; Yang X; Xu QA; Bian Z; Chen Z; Fan M Vaccine; 2009 Dec; 27(52):7459-66. PubMed ID: 19446592 [TBL] [Abstract][Full Text] [Related]
54. Respiratory FimA-Specific Secretory IgA Antibodies Upregulated by DC-Targeting Nasal Double DNA Adjuvant Are Essential for Elimination of Kataoka K; Kawabata S; Koyanagi K; Hashimoto Y; Miyake T; Fujihashi K Front Immunol; 2021; 12():634923. PubMed ID: 33717178 [TBL] [Abstract][Full Text] [Related]
55. Intranasal immunization with DNA vaccine coexpressing Der p 1 and ubiquitin in an allergic rhinitis mouse model. Ou J; Shi W; Xu Y; Tao Z Ann Allergy Asthma Immunol; 2014 Dec; 113(6):658-665.e1. PubMed ID: 25240330 [TBL] [Abstract][Full Text] [Related]
56. Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in chitosan nanoparticles. Zhao K; Zhang Y; Zhang X; Li W; Shi C; Guo C; Dai C; Chen Q; Jin Z; Zhao Y; Cui H; Wang Y Int J Nanomedicine; 2014; 9():389-402. PubMed ID: 24426783 [TBL] [Abstract][Full Text] [Related]
57. Enhancement of salivary IgA response to a DNA vaccine against Streptococcus mutans wall-associated protein A in mice by plasmid-based adjuvants. Han TK; Dao ML J Med Microbiol; 2007 May; 56(Pt 5):675-680. PubMed ID: 17446293 [TBL] [Abstract][Full Text] [Related]
58. Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen. Boyaka PN; Tafaro A; Fischer R; Leppla SH; Fujihashi K; McGhee JR J Immunol; 2003 Jun; 170(11):5636-43. PubMed ID: 12759444 [TBL] [Abstract][Full Text] [Related]